Streetbeat News

Regulatory

BIIB

BMY

Senator Bernie Sanders criticized the U.S. healthcare system, highlighting the disparity in life expectancy between rich and poor Americans. He emphasized the high cost of healthcare and its financial burden on patients, mentioning companies like Biogen and Bristol-Myers Squibb for their high drug prices.

Portfolio Pulse from Benzinga Neuro

September 10, 2024 | 2:12 am

META

Australia plans to introduce legislation banning children from using social media platforms like Meta's Instagram and Facebook, and TikTok, due to health concerns. The move follows criticism of social media companies and aims to address cyberbullying and harmful content exposure.

Portfolio Pulse from Benzinga Neuro

September 10, 2024 | 2:02 am

SIRI

Trading for a certain asset was halted at 7:50:00 p.m. ET due to pending news. The halt indicates that significant information is expected to be released, which could impact the asset's price.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 11:50 pm

PBM

Psyence Biomedical Ltd. (NASDAQ:PBM) has launched its first clinical trial site in Australia for a Phase IIb study on psilocybin as a treatment for Adjustment Disorder in palliative care patients. This marks a significant step in advancing psychedelic-based treatments, with patient screening starting immediately and data expected by 2025.

Portfolio Pulse from Juan Spínelli

September 09, 2024 | 10:02 pm

SPRY

ARS Pharmaceuticals has submitted a supplemental New Drug Application (sNDA) for neffy 1 mg, aimed at treating Type I allergic reactions, including anaphylaxis, in children weighing 15 to 30 kg.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 8:49 pm

ACB

CGC

CRON

HEXO

IIPR

MSOS

SMG

SNDL

YOLO

Former President Donald Trump's comments on rescheduling cannabis and supporting banking reforms led to a positive reaction in cannabis stocks. Notable gains were seen in companies like Trulieve Cannabis, Green Thumb Industries, and Canopy Growth. The market's response was more modest compared to previous surges.

Portfolio Pulse from Nicolás Jose Rodriguez

September 09, 2024 | 8:49 pm

TLT

Long-dated Treasury ETFs, particularly the iShares 20+ Year Treasury Bond ETF (TLT), have reached yearly highs as investors anticipate a favorable August CPI report. Economists and analysts expect continued moderation in inflation, which could influence Federal Reserve rate cut decisions.

Portfolio Pulse from Piero Cingari

September 09, 2024 | 8:34 pm

TRIB

Trinity Biotech has announced successful testing of its patented process to enhance its glucose biosensor technology, which will be used in its next-generation continuous glucose monitor (CGM). This development could improve the performance and stability of their CGM devices, which are crucial for diabetes management.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 8:26 pm

BIG

The New York Stock Exchange (NYSE) has initiated delisting proceedings against Big Lots, a retail company. This action could significantly impact the company's stock price and investor sentiment.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 8:17 pm

ARKK

TSLA

TSLL

TSLT

XLY

Elon Musk is being summoned by the UK Parliament to discuss the operations of his social media platform, X, amid concerns over algorithm use and content moderation. This comes as X's revenue reportedly collapsed by 84% under Musk's leadership, raising concerns among Tesla investors about potential stock liquidation. Tesla's stock saw a 2.59% increase, while ETFs holding Tesla shares also experienced gains.

Portfolio Pulse from Michael Juliano

September 09, 2024 | 8:00 pm